SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Hope for new psoriasis treatment
Fri October 30th - A possible new therapy for psoriasis has shown promise, a European conference has heard. More
Shop workers' risk of getting COVID-19
Fri October 30th - Customer-facing shop staff are about five times more likely to test positive for COVID-19 than their colleagues in other positions, a small American study has found. More
CA125 test better at predicting ovarian cancer
Fri October 30th - A readily available blood test is able to predict ovarian cancer risk more successfully than previously thought – particularly for the over 50s, according to newly published findings. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
NEWS FROM THE WEEK ENDING SEPTEMBER 11th 2020

Previous week's news

11/9/20 - plasmaMATCH trial success for breast cancer patients
A blood test that can identify a variety of mutations in advanced breast cancer can match women to effective targeted treatments, according to the early results of a major clinical trial. More

11/9/20 - Europe struggles with vaccine doubts
Europe may struggle to get the public to use any approved COVID-19 vaccine, according to an analysis published yesterday. More

10/9/20 - Genetic vulnerability in breast cancer cells discovered
A genetic vulnerability that is present in nearly 10% of all breast cancer tumours has been discovered, scientists have announced. More

10/9/20 - Form of natural hormone might prevent sarcopenia
A possible new treatment has been identified to restore the common age-related loss of muscle mass and strength. More

9/9/20 - UK alcohol report looks at harm to men
Efforts to reduce alcohol consumption among men need to confront the extent to which it is bound up with male identity in the UK, a report says today. More

8/9/20 - Genotype testing improves paediatric asthma care
Personalising treatments according to genetic differences could help some children with asthma, a medical congress will hear today (8 September 2020). More

7/9/20 - Link found between genes and penicillin allergy
A link between genes and penicillin allergy has been discovered by an international team of scientists. More

7/9/20 - Vaccines may not be silver bullet
Experts have warned against excessive optimism over COVID-19 vaccines – with one senior scientist warning they would not be a “silver bullet.” More

Printer friendly page Printer friendly page

CATEGORIES